TETROUS, INC. ANNOUNCES THE LAUNCH OF THE ENFIX TAC™ TO COMPLEMENT THE ENFIX RC™ AS THE ONLY PRODUCT LINE OF 100% DEMINERALIZED BONE ALLOGRAFT IMPLANTS THAT ARE DESIGNED TO ENHANCE REFORMATION OF THE ENTHESIS IN ROTATOR CUFF SURGERY

LOS ANGELES, Feb. 13, 2024 /PRNewswire/ — TETROUS, INC. unveils the addition of EnFix TAC to its family of EnFix™ demineralized bone allograft implants for use in rotator cuff surgery. The new implants will be showcased this week at the American Academy of Orthopaedic Surgeons (AAOS)…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks